Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long, relapsing, and atypical symptomatic course of COVID-19 in a B-cell-depleted patient after rituximab.

× No keyword cloud information.

15 in total

Review 1. Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed.

Authors: Dimitrios Daoussis; Lydia Leonidou; Christina Kalogeropoulou; Fotini Paliogianni; Argyrios Tzouvelekis
Journal: Rheumatol Int Date: 2021-08-19 Impact factor: 3.580

2. COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study.

Authors: Naomi J Patel; Kristin M D'Silva; Tiffany Y-T Hsu; Michael DiIorio; Xiaoqing Fu; Claire Cook; Lauren Prisco; Lily Martin; Kathleen M M Vanni; Alessandra Zaccardelli; Yuqing Zhang; Jeffrey A Sparks; Zachary S Wallace
Journal: medRxiv Date: 2021-08-09

3. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.

Authors: Jérôme Avouac; Elodie Drumez; Eric Hachulla; Raphaèle Seror; Sophie Georgin-Lavialle; Soumaya El Mahou; Edouard Pertuiset; Thao Pham; Hubert Marotte; Amélie Servettaz; Fanny Domont; Pascal Chazerain; Mathilde Devaux; Pascal Claudepierre; Vincent Langlois; Arsène Mekinian; Alexandre Thibault Jacques Maria; Béatrice Banneville; Bruno Fautrel; Jacques Pouchot; Thierry Thomas; René-Marc Flipo; Christophe Richez
Journal: Lancet Rheumatol Date: 2021-03-25

Review 4. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination.

Authors: Christof Specker; Peer Aries; Jürgen Braun; Gerd Burmester; Rebecca Fischer-Betz; Rebecca Hasseli; Julia Holle; Bimba Franziska Hoyer; Christof Iking-Konert; Andreas Krause; Klaus Krüger; Martin Krusche; Jan Leipe; Hanns-Martin Lorenz; Frank Moosig; Rotraud Schmale-Grede; Matthias Schneider; Anja Strangfeld; Reinhard Voll; Anna Voormann; Ulf Wagner; Hendrik Schulze-Koops
Journal: Z Rheumatol Date: 2021-09-07 Impact factor: 1.372

5. COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review.

Authors: Jessica M Jones; Aiman J Faruqi; James K Sullivan; Cassandra Calabrese; Leonard H Calabrese
Journal: Pathog Immun Date: 2021-05-14

6. Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β.

Authors: Donald C Vinh; Laurent Abel; Paul Bastard; Matthew P Cheng; Antonio Condino-Neto; Peter K Gregersen; Filomeen Haerynck; Maria-Pia Cicalese; David Hagin; Pere Soler-Palacín; Anna M Planas; Aurora Pujol; Luigi D Notarangelo; Qian Zhang; Helen C Su; Jean-Laurent Casanova; Isabelle Meyts
Journal: J Clin Immunol Date: 2021-06-08 Impact factor: 8.542

Review 7. Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections).

Authors: Cara D Varley; Kevin L Winthrop
Journal: Curr Rheumatol Rep Date: 2021-07-16 Impact factor: 4.592

Review 8. [Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020].

Authors: Hendrik Schulze-Koops; Christof Iking-Konert; Jan Leipe; Bimba Franziska Hoyer; Julia Holle; Frank Moosig; Peer Aries; Gerd Burmester; Christoph Fiehn; Andreas Krause; Hanns-Martin Lorenz; Matthias Schneider; Philipp Sewerin; Anna Voormann; Ulf Wagner; Klaus Krüger; Christof Specker
Journal: Z Rheumatol Date: 2020-09 Impact factor: 1.372

Review 9. The Care of the Leukemic Patients in Times of SARS-CoV-2.

Authors: Nabin Raj Karki; Thuy Le; Jorge Cortes
Journal: Curr Oncol Rep Date: 2021-08-03 Impact factor: 5.075

Review 10. [Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination].